Latest news with #NaveenJain
Time of India
5 days ago
- Business
- Time of India
9 Indian origin business tycoons in the US: Where did they study?
T he American startup ecosystem has long been a magnet for ambitious minds from around the world—but few communities have left as deep an imprint as Indian-origin entrepreneurs. These founders haven't just risen through the ranks of established corporations; they've built billion-dollar companies from scratch, pioneering technologies that power everything from smartphones and space missions to cybersecurity and data infrastructure. Armed with top-tier engineering degrees from institutions like the IITs and advanced education from global universities, these innovators turned bold ideas into global enterprises. Their journeys—often starting in modest towns across India—reflect a powerful blend of education, risk-taking, and long-term vision. Here's a closer look at 10 Indian-origin founders in the US who've made their mark on the global business map—and where their journey began academically. Jay Chaudhry : Founder and CEO, Zscaler Education: BTech – IIT BHU MS in Computer Engineering and MBA – University of Cincinnati Jay Chaudhry built Zscaler into a cybersecurity powerhouse from the ground up, taking it public in 2018. Born in rural Himachal Pradesh, his journey from a small government school to Silicon Valley IPO is powered by relentless innovation and a clear academic foundation in engineering and business. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Get ₹2Cr life cover@ ₹700 p.m. ICICI Pru Life Insurance Plan Get Quote Undo He also founded and sold four companies before Zscaler, proving his formula works. Vivek Ranadive: Founder, TIBCO Software Education: BS & MS in Electrical Engineering – MIT MBA – Harvard Business School Ranadivé built TIBCO Software into a real-time data leader, used by Wall Street and big enterprises. Originally from Mumbai, he moved to the US to attend MIT at 17. His blend of engineering and business enabled him to create a platform that changed how companies made real-time decisions. Later, he became the first Indian-origin owner of an NBA team, the Sacramento Kings. Naveen Jain : Founder, Infospace, Moon Express, Viome Education: BTech – IIT Roorkee (formerly University of Roorkee) MBA – XLRI Jamshedpur Naveen Jain first found success during the dot-com boom with Infospace, once one of the most valuable internet companies. He later shifted to moon exploration through Moon Express and preventive health via Viome. His academic training in engineering and business management gave him the versatility to shift between tech, space, and biotech entrepreneurship. Romesh Wadhwani: Founder, SymphonyAI & SAI Group Education: BTech – IIT Bombay MS & PhD in Electrical Engineering – Carnegie Mellon University Romesh Wadhwani founded Aspect Development, which he sold for $9.3 billion, and went on to create SymphonyAI, a group of AI-powered software companies serving various industries. His education in advanced engineering laid the groundwork for his understanding of enterprise systems and product development at scale. Today, he's also a leading philanthropist in education and digital skills. Sanjay Mehrotra: Co-founder, SanDisk Education: BS & MS in Electrical Engineering – University of California, Berkeley Executive Education – Stanford University Mehrotra co-founded SanDisk in 1988, helping make flash memory storage mainstream in consumer electronics. While he currently serves as CEO of Micron Technology, his true entrepreneurial legacy is rooted in building SanDisk into a multi-billion-dollar company. He holds over 70 patents, many based on the technical expertise acquired through his Berkeley education. Kanwal Rekhi: Co-founder, Excelan | Serial Angel Investor Education: BTech – IIT Bombay MS in Electrical Engineering – Michigan Tech University MBA – Santa Clara University Kanwal Rekhi co-founded Excelan, a networking company acquired by Novell, and became one of the first Indo-American tech entrepreneurs to take a company public on NASDAQ. He later became a prolific investor and helped establish TiE (The Indus Entrepreneurs), supporting startup founders of Indian origin. His academic path gave him both the technical core and strategic insight needed to navigate Silicon Valley. Dheeraj Pandey: Co-founder, Nutanix | Founder, DevRev Education: BTech – IIT Kanpur MS in Computer Science – University of Texas at Austin Pandey co-founded Nutanix, a pioneer in hyperconverged infrastructure, and led it to a successful IPO. After stepping down, he launched DevRev, a new-age platform connecting product-led teams directly with customers. His technical training from IIT and UT Austin shaped his deep product focus and engineering-first approach to company building. Ragy Thomas: Founder & CEO, Sprinklr Education: BE – Pondicherry University MBA – NYU Stern School of Business Ragy Thomas built Sprinklr into one of the world's leading customer experience platforms, serving clients like Microsoft and McDonald's. From a small-town engineering degree to an NYU MBA, he represents the growing number of founders who blend local academic roots with global ambition. Sprinklr went public in 2021, cementing his status as a next-gen enterprise software founder. Ash Ashutosh: Founder, Actifio (acquired by Google Cloud) Education: BTech – IIT Kanpur MS in Computer Science – Penn State University Ashutosh founded Actifio, a data virtualisation company acquired by Google Cloud in 2020. Prior to that, he built Serano Systems (acquired by Vitesse) and served in leadership roles at StorageNetworks and HP. His technical education from IIT and Penn State gave him the foundation to build scalable, enterprise-focused tech companies that attracted global acquirers. Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
Geek Wire
07-07-2025
- Business
- Geek Wire
Microsoft and the microbiome: Viome works with tech giant to optimize AI for molecular health
Naveen Jain, Viome CEO and founder, worked at Microsoft early in his career. (Viome Photo) Viome, a life sciences startup founded by veteran tech entrepreneur Naveen Jain, announced a collaboration with Microsoft to scale its molecular analysis platform — part of what Viome describes as a new era of AI-powered preventive health and wellness. Viome says Microsoft's cloud and AI infrastructure — specially tuned for its purposes in conjunction with the tech giant — will allow it to process biological data more efficiently. The idea is to expand access, reduce costs, and accelerate data processing and diagnostics. For Jain, it's a full-circle moment. Before founding such companies as InfoSpace, Intelius, and Moon Express, he was a Microsoft group manager in the 1980s and '90s, working on the business side of MSN while current Microsoft CEO Satya Nadella ran engineering for Microsoft's online division. 'Satya will someday be known as being one of the best CEOs in human history,' Jain said, using some of his trademark exuberance to describe Viome's work with the tech giant. 'He has changed Microsoft to be a company that's an unbelievably great partner.' Their collaboration addresses a massive scaling challenge. Viome says it has data from more than 1 million samples (including blood, saliva, and stool) from people in 106 countries, generating what it calls an unprecedented set of more than 10 quadrillion biological data points. Processing this data requires large memory footprints and high-speed storage, rather than the GPU-heavy computing more typical of everyday AI workloads. That difference is what drove the Microsoft collaboration, said Guru Banavar, Viome's CTO and head of AI, who previously led the team that built the foundational AI platform for IBM's Watson. Guru Banavar, Viome's CTO and head of AI. (Viome Photo) The underlying architecture developed by Microsoft and Viome 'was put together specifically to handle this type of bioinformatics with a very large-scale catalog, with a large-scale data set that's being transferred back and forth,' Banavar said. Other life sciences companies on Microsoft's Azure cloud and AI platform may also now benefit from this work, but Banavar said their early collaboration gives Viome a strategic advantage. The Bellevue, Wash.-based company's platform analyzes how genes and microbes in the body are actively functioning in real time, not just which ones are present in the body. Viome then uses that data to generate personalized health insights and recommendations. Viome does this by focusing on RNA, which plays a key role in how genes are expressed and regulated, rather than DNA, which serves as the body's more static genetic blueprint. The long-term idea is to create what it calls 'biological digital twins' — computer models that can predict how individuals will respond to specific foods and interventions. Viome is straddling the line between consumer wellness and clinical diagnostics as it looks to address issues ranging from depression to early-stage oral cancer. On the consumer side, it offers testing kits for saliva, blood and stool samples, with prices currently ranging from $229 to $299. Customers collect the samples at home and send them to Viome's lab for analysis. Results include personalized diet and nutrition insights, with options to subscribe to supplements and oral care products ranging from $79 to $199 a month. These offerings fall under the wellness category and are generally not subject to FDA regulation. According to Jain, Viome distinguishes itself in the wellness space by conducting blinded, placebo-controlled studies to validate its recommendations, publishing in peer-reviewed journals. A Viome testing kit and the company's app. (Viome Photo) The rise of AI and molecular analysis has led to a boom in competition in the personalized health sector, with companies like Thorne, ZOE, BIOHM and others offering various approaches to microbiome testing and wellness insights. At the same time, Viome has developed diagnostic tools that analyze RNA biomarkers to detect disease — including a test for early detection of oral cancer that has received FDA breakthrough device designation. That designation is designed to speed the review of promising technologies, but it is not equivalent to full FDA clearance or approval. Jain said he was inspired to start the company after his late father was diagnosed with pancreatic cancer. The experience led him to question why people develop chronic conditions, and whether diseases like cancer, diabetes and heart disease could be prevented by detecting earlier biological changes. The company's technology originated from a biodefense project at Los Alamos National Laboratory. This was an outgrowth of an approach Jain started pursuing in 2015 with his company BlueDot, aiming to commercialize scientific breakthroughs from institutions like Los Alamos and Oak Ridge National Laboratories. Founded in 2016, Viome has raised $225 million in total funding from investors including Khosla Ventures, Bold Capital, West River Group, Marc Benioff, Ezaki Glico, and Jain himself. Viome now employs close to 100 people and had nearly 100% year-over-year revenue growth, according to Jain, who declined to provide specific financials. Most customers, he said, not only take the tests but also subscribe to personalized nutrition products.
Cision Canada
07-07-2025
- Health
- Cision Canada
VIOME COLLABORATES WITH MICROSOFT TO DELIVER PREVENTIVE HEALTHCARE WITH ONE OF WORLD'S LARGEST RNA DATASETS
Viome's AI-Powered Platform Delivers Personalized Health Insights and Redefines Wellness Worldwide, Integrating Microsoft Azure BELLEVUE, Wash., July 7, 2025 /CNW/ -- Viome Life Sciences, a leader in AI-powered, RNA-based molecular diagnostics and personalized nutrition, today announced a collaboration with Microsoft to accelerate the next generation of preventive and personalized healthcare. As part of this collaboration, Viome will integrate its dataset of human and microbial gene expression, along with its cutting-edge bioinformatics and AI-powered recommendation engine, with Microsoft Azure infrastructure services, including Azure Ultra Disk Storage and Virtual Machines. Viome's AI platform transforms this data to deliver personalized nutrition and health insights designed to help individuals stay healthy, prevent chronic disease, and promote longevity. The integration of Viome's RNA science with Azure's secure and scalable HIPAA-compliant infrastructure services enables a new model of proactive home-based healthcare guided by molecular data. "We're excited to partner with Microsoft to create a biological digital twin for every individual, helping us make illness optional," said Naveen Jain, Founder and CEO of Viome. "This collaboration enables us to utilize large and complex biological datasets, delivering personalized health insights once thought impossible. Our mission is to empower people with the tools they need to stay healthy at home by using food, not pharmaceuticals, as medicine." Viome's Full Body Intelligence™ Test is one of the most advanced home-based health tests, analyzing both human and microbial gene expression from saliva, blood, and stool samples. Unlike static DNA tests, Viome's platform captures dynamic molecular activity, enabling precise, actionable nutrition and precision supplement recommendations to help reduce disease risk and optimize wellness. Biological data generated from Viome tests are processed in the cloud through Azure infrastructure services. Viome's AI models analyze human and microbial gene expression to detect early signs of inflammation, immune system dysfunction, and gut and molecular patterns that often precede chronic conditions. With more than 10 quadrillion biological data points, Viome's metatranscriptomic (RNA sequencing) dataset is the most comprehensive of its kind. To date, the company has completed over one million analyses across 106 countries. "Modern biology is based on data science," said Dr. Guru Banavar, Founding Chief Technology Officer at Viome. "What makes Viome unique is our ability to pair accurate, clinically relevant wet lab data with powerful AI-driven analysis. We're thrilled to collaborate with Microsoft to decode molecular signals at scale and transform raw biology into personalized health insights. With Microsoft, we can securely scale our existing platform to process petabyte-scale customer data and make preventive healthcare accessible to all." Viome's precision nutrition platform has been clinically shown to reduce symptoms of IBS by up to 58% and symptoms of depression and anxiety by up to 31%. It has also demonstrated a statistically significant reduction in HbA1c, the primary biomarker of diabetes. These results reinforce that food can be medicine, and that the future of disease prevention begins with personalized molecular insights. "Through our collaboration, we're gaining a deeper understanding of how cutting-edge biology and AI can come together to create impactful home-based health solutions," said Elena Bonfiglioli, General Manager, Worldwide Healthcare at Microsoft. "Integrating Microsoft Azure infrastructure services with Viome's scientific leadership and innovation are helping to better support the next generation of life science pioneers." Viome's proprietary AI platform delivers a growing suite of personalized health features, including: BioAge™ Score: Measures biological aging to guide longevity strategies. InflammAging™ Score: Tracks chronic inflammation driving disease and aging. Boosters & Blockers™: Personalizes nutrition to optimize health outcomes. Health Connections™: Links each person's biological data to over 25 chronic conditions, including diabetes, IBS, and depression. To explore Viome's Full Body Intelligence Test or learn more about personalized health, visit About Viome Viome is a longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Utilizing cutting-edge AI and the world's largest gene expression database, Viome's home-based tests offer individuals personalized nutritional guidance and innovative microbiome health products to enhance lifespan and health. Viome has empowered over half a million users with its unique approach that marries groundbreaking proprietary RNA sequencing methods with AI technology. This combination analyzes epigenetic biomarkers, providing robust, AI-driven health insights that contribute significantly to promoting a healthy lifespan. With its top-tier precision nutrition recommendations, Viome offers a comprehensive and personalized solution to aging. This is more than just health optimization; it's a revolution in understanding how we age and enabling us to do so with vitality and wellness. Media Contacts: Chris Hempel Spark Public Relations for Viome [email protected] 1-775-813-0285 SOURCE Viome Life Sciences
Time of India
19-05-2025
- Business
- Time of India
IMMT signs pact for research on critical minerals, sustainable mining
1 2 Bhubaneswar: The Institute of Minerals and Materials Technology (CSIR-IMMT) here on Monday signed a memorandum of understanding (MoU) with NTPC Mining Limited to pursue research initiatives of direct interest and those related to coal, mineral processing and extraction industry, including critical minerals. As part of the collaboration, the NTPC delegation visited CSIR-IMMT's critical minerals technology development facilities and deliberated on focused research and development and technological collaboration on critical minerals vital for Atmanirbhar Bharat and Viksit Bharat. NTPC Mining CEO Naveen Jain said the MoU is a significant milestone in its journey towards building a future-ready, environmentally responsible and innovation-led mining enterprise. "The collaboration directly aligns with our vision to be a benchmark organisation in safe, sustainable and efficient mining through technological excellence and environmental stewardship. By combining NTPC Mining's operational strength with CSIR-IMMT's cutting-edge research capabilities, we aim to drive transformative improvements in mine planning, mineral beneficiation and sustainable mine closure practices," he added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch Bitcoin và Ethereum - Không cần ví! IC Markets BẮT ĐẦU NGAY Undo Ramanuj Narayan, director of CSIR-IMMT, said the collaboration comes at a moment when India advances its efforts under the National Critical Minerals Mission. "NTPC Mining's growing role in resource security and its forward-looking approach to diversifying into critical minerals aligns well with our mandate to deliver science-led, scalable solutions to industry," he added. "At CSIR-IMMT, we have been steadily building infrastructure and capabilities to support the development and deployment of technologies in this space. Partnerships with industrial stakeholders are essential for translating research into impact, particularly when it comes to scaling up and commercial readiness. We are confident that the MoU will help catalyse technology-driven outcomes that contribute meaningfully to national priorities in critical minerals for sustainable development," he added. NTPC Mining Ltd supplied nearly 15% of NTPC's coal requirement in FY 2024–25, with production of over 134 million tonnes since its inception in 2018.
Yahoo
14-04-2025
- Health
- Yahoo
Viome Launches AI-Powered Full Body Intelligence™ Test To Help You Stay Healthy, Slow Aging, and Make Illness Optional
Viome's Full Body Intelligence Test™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening but why, and turns those insights into personalized daily nutrition advice to help you live healthier and longer. Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health conditions. BELLEVUE, Wash., April 14, 2025 /PRNewswire/ -- Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its most transformative consumer product, redefining how individuals understand, track, and improve their health through evolving biological insights. At the core of Viome's new experience is the radical idea that your genes are not your destiny, and your health outcomes are not static or predestined but measurable, modifiable, and within your control. Viome is the only company in the world that uses advanced RNA sequencing to decode your body's active gene expression and applies AI to translate that data into practical, daily health guidance. This includes what to eat, what to avoid, why you should eat certain foods, and how your personal health insights are connected to the most common diseases. "Our medical industrial complex is reactive and waits until we experience symptoms or develop a disease instead of helping us stay healthy in the first place," said Naveen Jain, Founder and CEO of Viome. "Symptoms that we feel are the body's last cry for help. At Viome, we believe true prevention begins by listening to your body's earliest whispers long before illness takes hold. Our technology decodes your biological signals and translates these insights into daily, personalized nutrition and supplement guidance so you can take control of your health before symptoms arise." Beyond DNA: A Test That Measures What's Actually Happening in Your Body Today Viome's Full Body Intelligence™ Test is a simple at-home kit that uses RNA sequencing from stool (gut microbiome), saliva (oral microbiome), and a finger-prick blood (cellular function) sample to reveal how your current diet and lifestyle impact your body's systems. Unlike static DNA tests that only show genetic potential or guess what might be happening in your body, Viome's RNA sequencing technology analyzes active human and microbial gene expression to detect early red flags like inflammation, microbial imbalance, and biological dysfunction before symptoms appear. Powering this experience is Viome's proprietary AI engine, which is trained on the world's largest gene expression database. It analyzes over 100 quadrillion biological data points from over one million samples across 106 countries. The platform also integrates over 20,000 peer-reviewed scientific publications, continuously evolving to reflect the latest cutting-edge research. This dynamic foundation of data allows Viome to deliver clinically grounded and highly personalized food and precision supplement recommendations designed to help reverse risk and extend healthspan. New Features included with Full Body Intelligence include: Health ConnectionsA first-of-its-kind feature that connects Viome health scores to early biological indicators of 25+ chronic conditions, including autoimmune, cognitive, digestive, metabolic, and oral health concerns. These connections are grounded in independent peer-reviewed science, Viome's proprietary AI models, and real-time gene expression data — making Viome's Full Body Intelligence one of the most powerful tools for personalized, preventative health. BioAge™ Score Measures millions of molecular data points to determine how fast your body is truly aging compared to your chronological age. This is driven by real-time molecular signals related to inflammation, metabolism, and cellular resilience, giving you a clear path to slow aging from the inside out. InflammAging™ ScoreTracks how chronic, low-grade inflammation — one of the most insidious drivers of aging and chronic disease — impacts your resilience and longevity. This score gives you a window into how to proactively manage inflammation through targeted science-backed nutrition and lifestyle strategies to help you fight it at the source. Personalized Boosters & Blockers™Viome's breakthrough approach to highlighting food-as-medicine - made personal, visible, and actionable. Every food, nutrient, and ingredient is tagged as a Booster (supports your biology and health goals) or Blocker (may fuel inflammation or imbalance). Each tag is personal and powered by real-time health scores. This level of functional insight turns your grocery list into a molecular strategy for prevention, where every bite is a targeted move toward optimal health. "What sets Viome apart is that we don't just measure your biology, but we measure change over time," said Dr. Momo Vuyisich, Viome's Chief Science Officer. "RNA allows us to track your body in action and how it responds and evolves with your environment, exercise, lifestyle, nutrition, sleep, and stress level. Our recommendations continuously adapt based on the biological signals we detect, guiding you according to what your body needs right now which may be very different from what it needed six months ago. In a world where genetic data is static, Viome delivers the opposite: a living, dynamic reflection of your biology that empowers you to course correct your health before a disease takes hold." A Consumer Product for a Health System That Doesn't Exist Yet Viome's new Full Body Intelligence experience bridges a long-standing gap in consumer health by offering a product that's not just smart or personalized but clinically grounded and rooted in functional, preventative care. "Health shouldn't be something you only think about when things go wrong," said Dr. Guru Banavar, Viome's Chief Technology Officer. "Just like you track your finances to build wealth, you should monitor your biology to stay ahead of your health. Your body is always changing, and your health plan needs to evolve with it. That's why we built an intelligent molecular feedback loop, giving you the power to take personalized action in real-time and invest in your health like you would your financial future." Viome's latest insights are available now to all Full Body Intelligence™ users. Learn more at About Viome Viome Life Sciences is a health technology company pioneering AI-powered, RNA-driven molecular diagnostics and precision nutrition to transform how we prevent chronic symptoms and extend healthy living. Viome's proprietary RNA sequencing and AI platform analyzes gene expression from the human body and microbiome to create a dynamic view of biological health. Viome's platform begins with the Full Body Intelligence Test, the most comprehensive at-home test available. By analyzing gene expression from stool, blood, and saliva, it reveals how diet and lifestyle impact key systems like the microbiome, immune function, inflammation, aging, and more. Viome translates this data into personalized food recommendations, custom-formulated supplements, and health scores that track inflammation, aging, microbial balance, and glycemic response to empower users to act early and stay well. Viome is also advancing clinical diagnostics, including the FDA Breakthrough Device-designated CancerDetect™ test for oral and throat cancer, and expanding into metabolic, digestive, and neurological disease detection. With over one million biological samples analyzed and the world's largest gene expression database, Viome is redefining preventive care. The company is backed by Khosla Ventures, Bold Capital Partners, Marc Benioff, and WestRiver Group. For more information:Viome Website: Research: on LinkedIn: Media Contacts: Helene VollbrachtChief Product Strategy Officer, Corporate Brand & Communicationshelene@ Chris HempelSpark Public View original content to download multimedia: SOURCE Viome Life Sciences
